Approaches for Optimal Use of Different COVID-19 Vaccines: Issues of Viral Variants and Vaccine Efficacy

This Viewpoint proposes ways to maximize vaccine efficacy and allocation given the rise of coronavirus variants and authorization of a Johnson & Johnson vaccine, including reserving the latter for younger healthier populations, boosting it with a single-dose messenger RNA (mRNA) vaccination, and...

Full description

Saved in:
Bibliographic Details
Published in:JAMA : the journal of the American Medical Association 2021-04, Vol.325 (13), p.1251-1252
Main Author: Moore, John P
Format: Article
Language:English
Subjects:
Coronaviruses
COVID-19
COVID-19 - immunology
COVID-19 vaccines
COVID-19 Vaccines - administration & dosage
COVID-19 Vaccines - immunology
Humans
Immunization
Mass Vaccination - organization & administration
mRNA
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Vaccine efficacy
Vaccines
Viral diseases
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This Viewpoint proposes ways to maximize vaccine efficacy and allocation given the rise of coronavirus variants and authorization of a Johnson & Johnson vaccine, including reserving the latter for younger healthier populations, boosting it with a single-dose messenger RNA (mRNA) vaccination, and single mRNA immunization of people with prior documented SARS-CoV-2 infection.
ISSN:0098-7484
1538-3598
DOI:10.1001/jama.2021.3465